Oramed Pharmaceuticals
ORMP
ORMP
21 hedge funds and large institutions have $1.96M invested in Oramed Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
26% less call options, than puts
Call options by funds: $17K | Put options by funds: $23K
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
21
Holding in Top 10
–
Calls
$17K
Puts
$23K
Top Buyers
| 1 | +$209K | |
| 2 | +$19.4K | |
| 3 | +$7K | |
| 4 |
Citigroup
New York
|
+$6.36K |
| 5 |
LC
Landaas & Company
Milwaukee,
Wisconsin
|
+$2K |
Top Sellers
| 1 | -$124K | |
| 2 | -$86K | |
| 3 | -$54.4K | |
| 4 |
Morgan Stanley
New York
|
-$33.1K |
| 5 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$18K |